N. S. Crouse

Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.

C. N. Coleman, N. Simone, C. Coleman, 2008, International journal of radiation oncology, biology, physics.

Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.

C. N. Coleman, N. Simone, C. Coleman, 2006, International journal of radiation oncology, biology, physics.

Post-collection,pre-measurement variables affecting VEGF levels in urine biospecimens

K. Camphausen, Sharon Smith, D. Citrin, 2007, Journal of cellular and molecular medicine.

Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens

K. Camphausen, D. Citrin, T. Scott, 2008, Journal of cellular and molecular medicine.

Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.

C. N. Coleman, K. Camphausen, C. Ménard, 2005, International journal of radiation oncology, biology, physics.

Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided High Dose Rate brachytherapy boost

C. N. Coleman, R. C. Susil, K. Camphausen, 2006, Radiation oncology.